UNIGE document Scientific Article
previous document  unige:125796  next document
add to browser collection

EASL Recommendations on Treatment of Hepatitis C 2018

CollaborationWith : Negro, Francesco
Published in Journal of Hepatology. 2018, vol. 69, no. 2, p. 461-511
Abstract Hepatitis C virus (HCV) infection is a major cause of chronic liver disease, with approximately 71 million chronically infected individuals worldwide. Clinical care for patients with HCV-related liver disease has advanced considerably thanks to an enhanced understanding of the pathophysiology of the disease, and because of developments in diagnostic procedures and improvements in therapy and prevention. These European Association for the Study of the Liver Recommendations on Treatment of Hepatitis C describe the optimal management of patients with acute and chronic HCV infections in 2018 and onwards.
Keywords Acute DiseaseChronic DiseaseDiagnostic Screening Programs/organization & administrationHepatitis C/diagnosis/physiopathology/therapyHumansPatient Care Management/methods/standardsRisk AssessmentRisk Factors
PMID: 29650333
Full text
Article (Published version) (2.7 MB) - document accessible for UNIGE members only Limited access to UNIGE
Research group Etudes et traitement de l'hépatite C et B (554)
(ISO format)
EUROPEAN ASSOCIATION FOR THE STUDY OF THE LIVER. EASL Recommendations on Treatment of Hepatitis C 2018. In: Journal of Hepatology, 2018, vol. 69, n° 2, p. 461-511. doi: 10.1016/j.jhep.2018.03.026 https://archive-ouverte.unige.ch/unige:125796

119 hits

0 download


Deposited on : 2019-11-08

Export document
Format :
Citation style :